Cologne (DE) / Walkersville, MD (USA), 26 March 2018. On 24 April 2018, Lonza is hosting a free 60-minute webinar on what are the best practices for connecting and integrating devices and systems in QC and production and how can the data captured be used to make better, more informed decisions.
Integrating devices and systems removes “information silos” within the laboratory, which helps to error-proof workflows by removing the data transcription step. If implemented effectively, integrated workflows can automate quality-control processes for regulated manufacturing.
Robert Lutskus, Global Production Delivery Manager, Lonza Bioscience Informatics, will cover the following topics:
- Technical considerations for interfaces
- Understanding raw data and determining what data belongs in which system
- Data integrity compliance
- Review by exception
- Validation
Anyone interested in attending the webinar can Register Here.
Date: Tuesday, 24 April 2018
Session 1: 8 AM EDT (New York) / 1 PM BST (London) / 2 PM CEST (Berlin)
Session 2: 11 AM PDT (Los Angeles) / 2 PM EDT (New York) / 3 PM BRT (Brazil)
Further information can be found on the MODA™ Paperless QC Micro Solution product page. By registering interest in the webinar, participants will receive a link once it is available to view “on demand” via the Lonza website.
More information about Lonza’s upcoming webinars is available here: www.lonza.com/qcwebinars.
About Lonza
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. As an integrated solutions provider, Lonza is boosting its value creation along and beyond the healthcare continuum with a strong focus on patient healthcare, consumer preventive healthcare and consumer’s healthy environment.
Lonza harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life. With the recent Capsugel acquisition, Lonza now offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries.
Benefiting from its regulatory expertise, Lonza is able to transfer its know-how from pharma to hygiene and fast-moving consumer goods all the way to coatings and composites and the preservation and protection of agricultural goods and other natural resources.
Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 100 sites and offices and approximately 14,500 full-time employees worldwide. The company generated sales of CHF 5.1 billion in 2017 with a CORE EBITDA of CHF 1.3 billion. Further information can be found at www.lonza.com
